One study found that in subjects with nonalcoholic fatty liver disease, taking a high dose of intravenous glutathione for four months improved their liver health
Acknowledgments The authors would like to recognize and thank Vince Abushaban, David Caprio, David Goldstrohm, Jenai Kailey, Dan LoTurco, Gates Roe, Larry Toft, Karen Trembler, and Dong Wang for their technical support
Bhamidipati, D, Haro-Silerio, JI, Ileana Dumbrava, EE, Fu, S, Hong, DS, Karp, DD, Naing, A, Pant, S, Piha-Paul, SA, Rodon Ahnert, J, Tsimberidou, AM, Johnson, A, Lee, MS, Dasari, NV, Raghav, KS, Morris, VK, Overman, MJ, Kopetz, S , Meric-Bernstam, F, Yap, TA
Companies that recognise and respond to these shifts will be best placed to succeed, while those slow to adapt risk losing relevance in an increasingly complex and dynamic landscape
These evaluations help determine whether a patient is an appropriate candidate for therapy
Gene expression of key regulators of mitochondrial biogenesis is sex dependent in mice with growth hormone receptor deletion in liver